Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 36,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Therapy Support Specialist (TSS) plays an important role in ensuring superior outcomes with HF10 therapy. The TSS interacts with patients to provide technical and product expertise. The position is part of the Therapy Optimization group and will work in collaboration with Sales Representatives, Therapy Consultants and Therapy Optimization Specialists.